Ibuprofeno Kern Pharma

Ibuprofen, the active ingredient in Ibuprofeno Kern Pharma, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It reduces pain, fever and inflammation and is commonly used in adults and children for conditions such as headache, musculoskeletal pain, and arthritis.

GNH USA supplies Ibuprofeno Kern Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution across multiple regions.

Ibuprofen acts by inhibiting cyclo‑oxygenase enzymes, providing relief in several painful or inflammatory conditions. - Pain: Reduces mild to moderate pain such as headache, dental pain, and musculoskeletal discomfort. - Fever: Lowers elevated body temperature associated with infections or inflammatory processes. - Inflammation: Decreases swelling and stiffness in conditions like osteoarthritis and rheumatoid arthritis. - Arthritis: Improves joint function and reduces pain in various forms of arthritis.

Ibuprofen may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: severe stomach or intestinal bleeding. - Renal impairment: reduced kidney function or acute kidney injury. - Hepatotoxicity: elevated liver enzymes or hepatitis. - Anaphylaxis: severe allergic reaction with airway compromise.

When using ibuprofen, several precautions should be observed to minimize risk. - Assess renal function: evaluate kidney health before initiating therapy in patients with pre‑existing renal disease. - Monitor gastrointestinal risk: consider protective agents for individuals with history of ulcers or bleeding. - Avoid in late pregnancy: contraindicated during the third trimester due to fetal cardiovascular risks. - Use lowest effective dose: prescribe the minimal dose needed for symptom control and limit duration. - Review concomitant NSAIDs: do not combine with other non‑steroidal anti‑inflammatory drugs to prevent additive toxicity. - Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and direct sunlight.

Ibuprofen can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - High‑dose aspirin: enhanced gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency. - ACE inhibitors or ARBs: may reduce antihypertensive effect and impair renal function. - Lithium: increased lithium serum concentrations.

Moderate Interactions (Monitor Closely): - Diuretics: potential reduction in renal clearance of ibuprofen. - Methotrexate: decreased elimination leading to toxicity. - Corticosteroids: additive risk of gastrointestinal ulceration. - Antihypertensives (e.g., beta‑blockers): possible attenuation of blood pressure control.